Receptos, Inc. (Nasdaq: RCPT) 34% HIGHER; announced that TOUCHSTONE, the Phase 2 trial of RPC1063 in ulcerative colitis (UC), met its primary endpoint and all...
Pain Therapeutics (Nasdaq: PTIE) 52.4% LOWER; reported it believes it will regain full development and commercial rights to REMOXY from Pfizer, Inc. On Friday, October...
Sarepta Therapeutics (SRPT) stock is getting crushed in pre-market trading Monday, down 8 points, or 33.79%, after the company said in a press release that...
The following is a list of notable articles to help get you through the lunch hour:SodaStream (SODA) Confirms 'Small-Scale' PepsiCo (PEP) Test -> Read this!Ford...
Vitae Pharmaceuticals, Inc. (Nasdaq: VTAE) 33% HIGHER; announced positive top-line results from clinical trials in treatment and prevention of Alzheimer's disease as part of the...
Infinera Corporation (INFN) ripping higher today with price breaking out to a fresh multi-year high over $13. Shares of the optical transport networking equipment provider...
Celator Pharmaceuticals, Inc. (Nasdaq: CPXX) 28.2% HIGHER; announced the pricing of an underwritten public offering of 6,611,150 shares of common stock and warrants to purchase...
UPGRADESGoldman Sachs raises Fifth Third Bancorp (Nasdaq: FITB) from Neutral to Buy with a price target of $22. Click Here for more color.Deutsche Bank moves...